Keynote speakers

Christophe Boldron (Evotec)

Christophe Boldron is a Molecular Architect with a strong background in medicinal chemistry and a particular interest in in silico sciences. He spent more than 20 years in the pharmaceutical industry, where he contributed to the nomination of numerous preclinical candidates. One of his favorite topics is how to accelerate drug discovery while increasing the quality of drug candidates.

Krystel El Hage (Qubit Pharmaceuticals)

Miriam Lopez Ramos (Servier)

After obtaining an engineering degree from École Polytechnique, she completed her PhD at Institut Curie in organic chemistry and molecular modeling, focusing on protein kinase inhibition for drug discovery. She took her first roles as a modeler at Syngenta (Switzerland) and AB Science (Paris) before moving to the biotech company Galapagos, in the Paris area. At Galapagos, she progressively evolved from providing modeling support for drug discovery projects to managerial roles. She led the Computational Chemistry group, which encompassed both project support and the development of new computational tools, including data science applied to small molecules. In parallel to her research activities, she was actively involved in modernizing data and laboratory informatics infrastructures. Following the downsizing at Galapagos, she recently joined the informatics department at Servier, where she oversees the deployment of data and AI tools as 'Head of Data and AI Products for Research and CMC.

Alexandre Varnek (Université de Strasbourg)

Alexandre Varnek is professor in theoretical chemistry at the University of Strasbourg and the head of the Chemoinformatics group at the Institute for Chemical Reactions Design and Discovery (Hokkaido University, Japan). He is recipient of the Herman Skolnik award of the American Chemical Society. Alexandre is the Editor-in Chief of the journal “Molecular Informatics (WILEY). His research focuses on chemoinformatics and molecular modeling.